Parkinson'
Conditions
Interventions
None listed
Sponsors
Osaka Toneyama Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with Parkinson's disease by the British Brain Bank Clinical Criteria 2) H & Y classification II degree or higher 3) Patients aged between 20 and 85 at the time of consent 4) Gender does not matter 5) Patients who have voluntarily consented to the document
Exclusion criteria
Exclusion criteria: 1) Patients with serious physical symptoms other than Parkinson's disease (cardiac / hepatic / renal dysfunction, hematopoietic disorders, etc.) 2) Viral hepatitis: HBsAg positive or HCV antibody positive 3) Women who are pregnant or may become pregnant 4) Patients with a history of hypersensitivity to the study drug 5) Patients with drug addiction / alcohol dependence 6) Patients with serious psychiatric symptoms (confusion, hallucinations, delusions, abnormal behavior, etc.) within 3 months before obtaining the consent form 7) Other patients who the doctor in charge deems inappropriate to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Questionnaire including visual analogue scale (2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection) | — |
Secondary
| Measure | Time frame |
|---|---|
| Unified Parkinson Disease Rating Scale, functional evaluation in rehabilitation, evaluation of waist bending angle (2 weeks, 4 weeks, 8 weeks, 12 weeks, 24 weeks after the block injection) | — |
Countries
Japan
Contacts
Public ContactTakuyuki Endo
Osaka Toneyama Medical Center Neurology
Outcome results
None listed